AU3056299A - Methods for isolating osteoclast precursor cells and inducing the differentiation of the same into osteoclasts - Google Patents

Methods for isolating osteoclast precursor cells and inducing the differentiation of the same into osteoclasts

Info

Publication number
AU3056299A
AU3056299A AU30562/99A AU3056299A AU3056299A AU 3056299 A AU3056299 A AU 3056299A AU 30562/99 A AU30562/99 A AU 30562/99A AU 3056299 A AU3056299 A AU 3056299A AU 3056299 A AU3056299 A AU 3056299A
Authority
AU
Australia
Prior art keywords
preosteoclasts
osteoclasts
precursor cells
differentiation
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30562/99A
Inventor
Tomoko Maeda
Takahiro Ochi
Ryuji Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU3056299A publication Critical patent/AU3056299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0643—Osteoclasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/21—Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

This invention relates to: a method for differentiating osteoclast precursor cells (preosteoclasts) into osteoclasts, which comprises culturing the preosteoclasts in the absence of accessory cells; a method for isolating preosteoclasts, which comprises culturing peripheral blood or joint fluid in the absence of cytokine for 1 to 3 weeks; an preosteoclasts, which is obtainable by the above method; a method for differentiating the preosteoclasts obtained by the above method into osteoclasts, which comprises culturing the preosteoclasts in the absence of accessory cell; an osteoclast, which is obtainable by the above method; a method for screening agents for treating metabolic bone diseases, which comprises using the preosteoclasts or the osteoclasts as described above; and agents for treating metabolic bone diseases, which is obtainable by the above screening method.
AU30562/99A 1998-04-08 1999-04-06 Methods for isolating osteoclast precursor cells and inducing the differentiation of the same into osteoclasts Abandoned AU3056299A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP10/95962 1998-04-08
JP9596298 1998-04-08
JP17040798 1998-06-18
JP10/170407 1998-06-18
PCT/JP1999/001803 WO1999053023A1 (en) 1998-04-08 1999-04-06 Methods for isolating osteoclast precursor cells and inducing the differentiation of the same into osteoclasts

Publications (1)

Publication Number Publication Date
AU3056299A true AU3056299A (en) 1999-11-01

Family

ID=26437128

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30562/99A Abandoned AU3056299A (en) 1998-04-08 1999-04-06 Methods for isolating osteoclast precursor cells and inducing the differentiation of the same into osteoclasts

Country Status (7)

Country Link
US (2) US6861257B1 (en)
EP (1) EP1070757B1 (en)
JP (1) JP4271857B2 (en)
AT (1) ATE288477T1 (en)
AU (1) AU3056299A (en)
DE (1) DE69923550T2 (en)
WO (1) WO1999053023A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002097121A1 (en) * 2001-05-28 2002-12-05 Nordic Bioscience A/S Method for assaying osteoclast recruitment and resorption
WO2006128029A2 (en) * 2005-05-25 2006-11-30 University Of Virginia Patent Foundation Production of osteoclasts from adipose tissues
US20070082395A1 (en) * 2005-10-11 2007-04-12 Biancamaria Baroli Production of normal human osteoclasts
IN2014DN06624A (en) 2005-10-18 2015-07-10 Univ Colorado
CA2723114C (en) 2008-05-16 2018-02-27 Taiga Biotechnologies, Inc. Antibodies and processes for preparing the same
CN102083970B (en) 2008-07-21 2014-10-22 泰加生物工艺学公司 Differentiated anucleated cells and method for preparing the same
DE102008036060A1 (en) * 2008-08-04 2010-02-25 Technische Universität Dresden Cell-based method and means for bone formation
WO2010025421A2 (en) 2008-08-28 2010-03-04 Taiga Biotechnologies, Inc. Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
DK2877189T3 (en) 2012-07-20 2021-02-22 Taiga Biotechnologies Inc IMPROVED RECONSTITUTION AND AUTHOR CONSTITUTION OF THE HEMOPOETICAL CHAMBER
US9365825B2 (en) 2013-03-11 2016-06-14 Taiga Biotechnologies, Inc. Expansion of adult stem cells in vitro
US10272115B2 (en) 2013-03-11 2019-04-30 Taiga Biotechnologies, Inc. Production and use of red blood cells
WO2017011456A1 (en) * 2015-07-16 2017-01-19 Velo3D, Inc. Material-fall three-dimensional printing
IL281425B (en) 2016-12-02 2022-07-01 Taiga Biotechnologies Inc Nanoparticle formulations
US10149898B2 (en) 2017-08-03 2018-12-11 Taiga Biotechnologies, Inc. Methods and compositions for the treatment of melanoma
US11478532B2 (en) 2017-12-03 2022-10-25 National Centre For Cell Science Therapeutic intervention for osteoporosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018615A1 (en) * 1991-04-09 1992-10-29 Indiana University Foundation System and process for supporting hematopoietic cells
EP0614485B1 (en) * 1991-10-23 2002-07-17 Nexell Therapeutics Inc. Methods for selectively expanding cd34 positive cells
US6103522A (en) * 1994-07-20 2000-08-15 Fred Hutchinson Cancer Research Center Human marrow stromal cell lines which sustain hematopoiesis
WO1996007733A1 (en) * 1994-09-09 1996-03-14 Zymogenetics, Inc. Preparation of immortalized cells
US5830682A (en) * 1994-09-09 1998-11-03 Zymogenetics Preparation of immortalized cells

Also Published As

Publication number Publication date
EP1070757A1 (en) 2001-01-24
EP1070757B1 (en) 2005-02-02
DE69923550D1 (en) 2005-03-10
DE69923550T2 (en) 2006-02-16
US20050003528A1 (en) 2005-01-06
US6861257B1 (en) 2005-03-01
WO1999053023A1 (en) 1999-10-21
EP1070757A4 (en) 2003-04-09
ATE288477T1 (en) 2005-02-15
JP4271857B2 (en) 2009-06-03

Similar Documents

Publication Publication Date Title
AU3056299A (en) Methods for isolating osteoclast precursor cells and inducing the differentiation of the same into osteoclasts
AU8487998A (en) Novel apparatus and method for isolated pelvic perfusion
DE69630455D1 (en) PRODUCTION OF BETA -GLUKAN-MANNAN PREPARATIONS BY AUTOLYSIS OF CELLS UNDER SPECIFIC pH, TEMPERATURE AND TIME CONDITIONS
AU641641B2 (en) Process for isolating nucleic acid
AU6328094A (en) Saccharin derivative proteolytic enzyme inhibitors
TW225532B (en)
EP2210947A3 (en) Method for producing secreted proteins
WO2003014317A3 (en) Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof
GB9626643D0 (en) Compounds
EP0471756A4 (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
AU2003287015A1 (en) Method of isolation and self-assembly of small protein particles from blood and other biological materials
AU1686288A (en) Amperometric method for the quantitative determination of 1,4-dihydronicotinamide adenine dinucleotide (nadh) in solution
WO2000034442A3 (en) Application of shear flow stress to smooth muscle cells for the production of implantable structures
ES2099714T3 (en) PROCEDURE OF ENDOPROTEOLYTIC TREATMENT OF PROTEINS (PRECURSORS) AND OF MICROBIOLOGICAL PRODUCTION OF PROTEINS.
AU2534595A (en) Angiotensin ii for improving fertilization
EP1499710A4 (en) Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering
WO1997038124A3 (en) Enzymatic process for stereoselective preparation of therapeutic amides
AU1859900A (en) Device for culturing human or animal tissue
AU2353995A (en) Process for the lysis of a culture of lactic acid bacteria by means of a lysin, and uses of the resulting lysed culture
AU2182801A (en) Method for producing adherent animal cells
ID24225A (en) A PROCESS FOR SIMPLE BIOLOGICAL REHABILITATION OF SOIL CONTAMINATED BY CONTAMINATION IN LONG TIME BASED ON MINERAL OIL
WO2004030628A3 (en) Adult bone marrow derived stem cells
AU2399688A (en) Method for culturing plant tissue
JPS557015A (en) Proline acylase, its preparation and preparation of l-proline
EP1142989A3 (en) Chondrocyte cell-lines

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase